Home » 論文ナビSCOPE » キーワード分析 » 【論文データ】non-small-cell lung cancer (NSCLC)（非小細胞肺癌）の国内研究動向まとめ 【論文データ】non-small-cell lung cancer (NSCLC)（非小細胞肺癌）の国内研究動向まとめ 論文ナビは研究者によって運営される論文解説プラットフォームです。このページでは、最近二年間(2016-2017)で発表された文献データを独自に収集・集計して分かりやすくまとめました。論文キーワードマップ、代表的な研究機関、頻出キーワード、分野のシェア、分野関連図、関連文献等により、今までない情報を提供します。 統計データ non-small-cell lung cancer (NSCLC)epidermal growth factor receptor (EGFR)bevacizumablung cancernivolumabprognosisEGFR mutationchemotherapyalectiniberlotinibafatinibadenocarcinomacarboplatinstereotactic radiotherapyinterstitial lung diseasePD-L1S-1prognostic factorelderlypemetrexedgefitinibdocetaxelsurgeryepithelial-mesenchymal transitionimmunotherapyT790Mpostoperative recurrenceoverall survivalanaplastic lymphoma kinase (ALK)TNM classificationEGFR-TKIepidermal growth factor receptor mutationJapaneseimmune checkpoint inhibitoradjuvant chemotherapycrizotiniblobectomymutationradiotherapyacquired resistancetumor-infiltrating lymphocytenab-paclitaxelelderly patientslymph node metastasisbrain metastasestyrosine kinase inhibitorT790M mutationCT scanlung cancer stagingmultiple tumorsplasmabiomarkerinterstitial pneumoniaTGF-betaosimertinibpositron emission tomography (PET)computed tomography (CT)ramucirumabsquamous cell carcinoma (SCC)second line chemotherapyimmunohistochemistrymaintenance therapyJapandual-energy CTALK rearrangementpharmacokineticsphase I studyleptomeningeal carcinomatosiscisplatinvascular endothelial growth factor (VEGF)acute exacerbationpredictive factorapoptosistoxicityprognostic markerperfusionMET amplificationchemoradiotherapysurgical resectionlymph node dissectionP-glycoproteindrug resistanceSBRToxidative stresschemoresistancemolecular target drugER stresspaclitaxelpredictive biomarkerprecision medicinemeta-analysisefficacyprospective studyretrospective studydigital PCRsurvivalsmokingp53lung adenocarcinomaprogression-free survivalpulmonary resectiondose escalationproton beam therapycachexiacancer cachexiasarcopeniacancer stem cellscytologygeriatric nutritional risk indexsegmentectomyhepatocyte growth factorPET-CTtherapeutic effectEML4 ALKcell deathctDNAresistancephase III studyamrubicinSUVmaxFDG-PETdisease progressionradiation pneumonitiscell-free DNAhepatocellular carcinoma (HCC)postoperativefollow-upreal-time polymerase chain reaction (PCR)ABCB1Monte Carlo simulationmodeling and simulationcost-effectivenesscancer chemotherapyexosomeshared decision makingpirfenidoneinduction chemotherapyinduction therapycancer cellshistologyPD 1adverse eventsalbuminhypoalbuminemiaperformance statushemodialysischronic kidney disease (CKD)adenosinethymidylate synthaseangiogenesisFDG-PET/CTbeta-cateningemcitabineradiationtumor progressionsignal transductionnasogastric tubecarbon ion radiotherapyliquid biopsyeribulinMUC-1drug-induced lung injuryglutathionereactive oxygen species (ROS)early detectionimmunosuppressionlymphangiogenesiscase reportidiopathic pulmonary fibrosisgenderTP53multivariate analysisvalidationdisease-free survivalcurative resectionendoscopic ultrasonographyradiosurgerynext-generation sequencingT-cell receptorimmunogenicityirradiationpembrolizumabstagingpathologydexamethasonefocal adhesion kinasenitric oxide (NO)C-reactive protein (CRP)body mass indexskeletal muscle massprospectivecohort studyHMGB1PAI-1brain natriuretic peptide (BNP)small cell lung cancer (SCLC)phase II studyrelapse-free survivalNOTCHBimCD44K rastumorigenesisbiopsyNRF-2PIK3CAchronic obstructive pulmonary disease (COPD)dasatinibCOX-2tumor microenvironmentscalable processor architecture (SPARC)carcinoembryonic antigen (CEA)pulmonary functionmitochondriatumor markerhistone deacetylase inhibitorcancer immunotherapyintegrinEpCAMcirculating tumor cellswedge resectionmethylationkinase inhibitorchemoradiation therapycinnamaldehydemigrationcell proliferationpharyngeal cancergastric cancerSrcDNA damage responseBRCA1immune evasionpharmacogenomicsalkyl chain lengthstructure-activity relationshipcaspaseesophagusLC-MS-MSphospholipidcross-validationbioequivalencerenal dysfunctionmalignant pleural mesotheliomaamplificationPD-L2BIMExtracellular signal-regulated kinase (ERK)PP2Acombinationcross-sectional areaHIVAIDScellulitisperitoneal carcinomatosisfeasibility studyJapanese patientsBaxlate recurrenceneuropathic painpregabalinthoracoscopic surgerybleedingcolorectal cancerhypertensionendocytosisMETBRAFsequencingNK celltransgenic micecerebrospinal fluid (CSF)MEK inhibitorMAPK pathwaycardiotoxicitycontrast enhancementIL-6fibroblastAnti-PD-1 antibodyclinical trialaprepitantchemotherapy-induced nausea and vomitingprostate canceresophageal squamous cell carcinomafeature extractionbreast cancerprincipal component analysis (PCA)metabolic tumor volumemorbidityfistulaquality-of-life (QOL)body weight lossrandomized controlled trialKRAS mutationSp15-fluorouracildoxorubicinadenovirushepatotoxicitysalvage surgery
